Share Price and Basic Stock Data
Last Updated: February 2, 2026, 2:40 am
| PEG Ratio | 0.46 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Nucleus Software Exports Ltd operates within the IT Consulting and Software sector, showcasing a robust revenue growth trajectory. For the fiscal year ending March 2025, the company reported sales of ₹832 Cr, a significant increase from ₹634 Cr in the previous fiscal year. The trailing twelve months (TTM) revenue stood at ₹866 Cr, indicating a consistent upward trend. Quarterly sales figures also reflect stability, with the latest reported revenue of ₹205 Cr for September 2023, slightly down from ₹207 Cr in June 2023. This fluctuation is typical in the IT sector, where quarterly performance can vary due to project timelines and client budgets. The company’s operational performance is underscored by an operating profit margin (OPM) of 20% for FY 2025, which is considerably higher than the industry average, showcasing its capability to manage costs effectively while driving revenues.
Profitability and Efficiency Metrics
Nucleus Software reported a net profit of ₹163 Cr for FY 2025, down from ₹192 Cr in FY 2024, reflecting a net profit margin of 19.58%. The decline in profitability is noteworthy, especially when juxtaposed with the company’s historical performance where net profit had increased significantly in prior years. Efficiency metrics reveal a return on equity (ROE) of 20.01% and return on capital employed (ROCE) of 25.25%, both of which are commendable compared to sector averages. The interest coverage ratio (ICR) stood at an impressive 312.81x, indicating that the company can easily meet its interest obligations, reflecting strong financial health. The cash conversion cycle (CCC) has improved to 60 days, demonstrating enhanced efficiency in managing receivables and payables, although it remains higher than the typical IT sector range.
Balance Sheet Strength and Financial Ratios
The balance sheet of Nucleus Software exhibits strong fundamentals, with total assets of ₹1,153 Cr and a minimal borrowing of ₹8 Cr, underscoring the company’s low leverage. This is complemented by reserves which rose to ₹822 Cr as of September 2025, indicating a solid buffer for future investments or downturns. The company’s book value per share stood at ₹309.24 for FY 2025, providing a strong foundation for shareholder equity. The price-to-book value (P/BV) ratio was recorded at 2.59x, falling within a reasonable range compared to industry norms. Additionally, the current ratio of 1.93x signifies adequate liquidity to cover short-term liabilities, which is vital for operational stability. However, the declining trend in net profit from the previous fiscal year raises questions about the sustainability of this balance sheet strength in the future.
Shareholding Pattern and Investor Confidence
Nucleus Software’s shareholding pattern reveals a strong promoter backing, with promoters holding 73.59% of the company’s equity, indicating significant insider confidence. Foreign institutional investors (FIIs) accounted for 5.18%, while domestic institutional investors (DIIs) held 1.49%. The public shareholding stood at 19.75%, reflecting a moderate level of retail investor interest. Over the past year, the number of shareholders has fluctuated, with a noted increase to 42,192 as of September 2025, suggesting growing investor interest. However, the slight decline in FII participation from earlier highs could be a point of concern regarding global investor sentiment towards the company. The strong promoter stake typically signals confidence in the company’s future prospects, but the overall investor confidence would benefit from improved financial performance in subsequent quarters.
Outlook, Risks, and Final Insight
Looking ahead, Nucleus Software is well-positioned to leverage its strong balance sheet and operational efficiencies to navigate market challenges. However, risks remain, particularly the recent decline in net profit, which could affect investor sentiment and stock performance. Additionally, the company’s reliance on a few key clients for revenue could expose it to significant revenue risks if those clients reduce spending. If Nucleus can enhance its profitability through strategic cost management and diversify its client base, it may see renewed investor confidence and stock appreciation. Conversely, failure to address profitability concerns could lead to a decline in market capitalization and investor interest. The company’s ability to maintain its operational efficiency while enhancing revenue growth will be crucial in determining its future trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IDream Film Infrastructure Company Ltd | 4.99 Cr. | 332 | 332/108 | 302 | 0.00 % | % | % | 10.0 | |
| I Power Solutions India Ltd | 13.2 Cr. | 22.3 | 22.3/15.1 | 11.0 | 0.00 % | 11.6 % | 16.9 % | 10.0 | |
| Hypersoft Technologies Ltd | 92.0 Cr. | 56.6 | 101/19.4 | 45.1 | 9.97 | 0.00 % | 20.6 % | 9.07 % | 10.0 |
| Euphoria Infotech (India) Ltd | 10.7 Cr. | 36.8 | 64.9/33.1 | 7.21 | 58.7 | 0.00 % | 16.2 % | 11.5 % | 10.0 |
| AccelerateBS India Ltd | 43.8 Cr. | 128 | 134/67.0 | 29.8 | 15.0 | 0.78 % | 22.2 % | 17.6 % | 10.0 |
| Industry Average | 130,550.07 Cr | 813.87 | 42.95 | 156.22 | 0.78% | 20.61% | 18.63% | 7.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 130 | 169 | 206 | 207 | 205 | 204 | 210 | 195 | 202 | 206 | 229 | 218 | 214 |
| Expenses | 119 | 121 | 123 | 144 | 153 | 156 | 152 | 166 | 170 | 172 | 154 | 184 | 190 |
| Operating Profit | 11 | 48 | 83 | 63 | 52 | 48 | 58 | 29 | 32 | 33 | 74 | 34 | 23 |
| OPM % | 9% | 28% | 40% | 30% | 25% | 23% | 28% | 15% | 16% | 16% | 33% | 16% | 11% |
| Other Income | 9 | 9 | 10 | 13 | 12 | 12 | 14 | 15 | 19 | 16 | 17 | 18 | 16 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 4 |
| Profit before tax | 15 | 52 | 89 | 72 | 60 | 56 | 68 | 40 | 47 | 45 | 88 | 48 | 35 |
| Tax % | 26% | 26% | 24% | 25% | 26% | 26% | 24% | 24% | 29% | 22% | 26% | 27% | 26% |
| Net Profit | 11 | 38 | 68 | 54 | 45 | 41 | 52 | 30 | 33 | 35 | 65 | 35 | 26 |
| EPS in Rs | 4.12 | 14.32 | 25.27 | 20.01 | 16.65 | 15.43 | 19.47 | 11.28 | 12.56 | 13.28 | 24.60 | 13.37 | 9.99 |
Last Updated: December 29, 2025, 6:35 pm
Below is a detailed analysis of the quarterly data for Nucleus Software Exports Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 214.00 Cr.. The value appears to be declining and may need further review. It has decreased from 218.00 Cr. (Jun 2025) to 214.00 Cr., marking a decrease of 4.00 Cr..
- For Expenses, as of Sep 2025, the value is 190.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 184.00 Cr. (Jun 2025) to 190.00 Cr., marking an increase of 6.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 23.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Jun 2025) to 23.00 Cr., marking a decrease of 11.00 Cr..
- For OPM %, as of Sep 2025, the value is 11.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Jun 2025) to 11.00%, marking a decrease of 5.00%.
- For Other Income, as of Sep 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Jun 2025) to 16.00 Cr., marking a decrease of 2.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 4.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.00 Cr. (Jun 2025) to 4.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 48.00 Cr. (Jun 2025) to 35.00 Cr., marking a decrease of 13.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Jun 2025) to 26.00%, marking a decrease of 1.00%.
- For Net Profit, as of Sep 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Jun 2025) to 26.00 Cr., marking a decrease of 9.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 9.99. The value appears to be declining and may need further review. It has decreased from 13.37 (Jun 2025) to 9.99, marking a decrease of 3.38.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:53 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 346 | 353 | 349 | 372 | 412 | 484 | 521 | 514 | 497 | 634 | 826 | 832 | 866 |
| Expenses | 278 | 287 | 318 | 319 | 353 | 405 | 427 | 384 | 460 | 478 | 606 | 664 | 701 |
| Operating Profit | 68 | 66 | 31 | 54 | 59 | 79 | 94 | 129 | 37 | 157 | 220 | 168 | 165 |
| OPM % | 20% | 19% | 9% | 14% | 14% | 16% | 18% | 25% | 7% | 25% | 27% | 20% | 19% |
| Other Income | 24 | 33 | 26 | 32 | 29 | 27 | 37 | 39 | 35 | 34 | 51 | 66 | 66 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 8 | 12 | 12 | 11 | 7 | 10 | 14 | 14 | 15 | 19 | 15 | 15 | 14 |
| Profit before tax | 83 | 87 | 44 | 74 | 80 | 96 | 117 | 154 | 56 | 171 | 256 | 219 | 216 |
| Tax % | 23% | 25% | 26% | 11% | 22% | 23% | 24% | 23% | 26% | 25% | 25% | 26% | |
| Net Profit | 64 | 65 | 32 | 66 | 63 | 75 | 89 | 118 | 41 | 128 | 192 | 163 | 161 |
| EPS in Rs | 19.87 | 19.98 | 10.03 | 20.43 | 21.54 | 25.67 | 30.64 | 40.62 | 15.28 | 47.73 | 71.56 | 61.92 | 61.24 |
| Dividend Payout % | 30% | 25% | 50% | 24% | 37% | 35% | 29% | 22% | 46% | 21% | 17% | 20% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 1.56% | -50.77% | 106.25% | -4.55% | 19.05% | 18.67% | 32.58% | -65.25% | 212.20% | 50.00% | -15.10% |
| Change in YoY Net Profit Growth (%) | 0.00% | -52.33% | 157.02% | -110.80% | 23.59% | -0.38% | 13.92% | -97.84% | 277.45% | -162.20% | -65.10% |
Nucleus Software Exports Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 19% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 72% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 15% |
| 3 Years: | 36% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 17% |
| 3 Years: | 20% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 11:50 am
Balance Sheet
Last Updated: December 10, 2025, 3:10 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 29 | 29 | 29 | 29 | 27 | 27 | 27 | 26 | 26 |
| Reserves | 365 | 406 | 425 | 503 | 432 | 480 | 532 | 643 | 467 | 584 | 751 | 788 | 822 |
| Borrowings | 0 | 0 | 1 | 0 | 0 | 0 | 6 | 6 | 2 | 6 | 5 | 2 | 8 |
| Other Liabilities | 116 | 118 | 123 | 131 | 184 | 177 | 196 | 206 | 241 | 257 | 332 | 337 | 373 |
| Total Liabilities | 513 | 556 | 581 | 665 | 645 | 685 | 763 | 885 | 737 | 874 | 1,114 | 1,153 | 1,230 |
| Fixed Assets | 61 | 58 | 54 | 48 | 48 | 47 | 57 | 50 | 59 | 50 | 59 | 61 | 77 |
| CWIP | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 |
| Investments | 224 | 170 | 245 | 441 | 387 | 424 | 475 | 635 | 480 | 525 | 649 | 641 | 676 |
| Other Assets | 228 | 328 | 281 | 176 | 210 | 214 | 231 | 200 | 198 | 298 | 406 | 451 | 477 |
| Total Assets | 513 | 556 | 581 | 665 | 645 | 685 | 763 | 885 | 737 | 874 | 1,114 | 1,153 | 1,230 |
Below is a detailed analysis of the balance sheet data for Nucleus Software Exports Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00 Cr..
- For Reserves, as of Sep 2025, the value is 822.00 Cr.. The value appears strong and on an upward trend. It has increased from 788.00 Cr. (Mar 2025) to 822.00 Cr., marking an increase of 34.00 Cr..
- For Borrowings, as of Sep 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 2.00 Cr. (Mar 2025) to 8.00 Cr., marking an increase of 6.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 373.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 337.00 Cr. (Mar 2025) to 373.00 Cr., marking an increase of 36.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,230.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,153.00 Cr. (Mar 2025) to 1,230.00 Cr., marking an increase of 77.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 77.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Mar 2025) to 77.00 Cr., marking an increase of 16.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 676.00 Cr.. The value appears strong and on an upward trend. It has increased from 641.00 Cr. (Mar 2025) to 676.00 Cr., marking an increase of 35.00 Cr..
- For Other Assets, as of Sep 2025, the value is 477.00 Cr.. The value appears strong and on an upward trend. It has increased from 451.00 Cr. (Mar 2025) to 477.00 Cr., marking an increase of 26.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,230.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,153.00 Cr. (Mar 2025) to 1,230.00 Cr., marking an increase of 77.00 Cr..
Notably, the Reserves (822.00 Cr.) exceed the Borrowings (8.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 68.00 | 66.00 | 30.00 | 54.00 | 59.00 | 79.00 | 88.00 | 123.00 | 35.00 | 151.00 | 215.00 | 166.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 44 | 87 | 90 | 60 | 70 | 54 | 63 | 63 | 61 | 100 | 73 | 60 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 44 | 87 | 90 | 60 | 70 | 54 | 63 | 63 | 61 | 100 | 73 | 60 |
| Working Capital Days | -5 | 14 | 7 | -43 | -66 | -51 | -53 | -61 | -77 | -16 | -38 | -43 |
| ROCE % | 21% | 19% | 10% | 15% | 16% | 19% | 21% | 22% | 6% | 27% | 32% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| WhiteOak Capital Flexi Cap Fund | 167,297 | 0.22 | 15.31 | 113,333 | 2025-12-08 02:20:10 | 47.62% |
| WhiteOak Capital Multi Cap Fund | 43,764 | 0.14 | 4.01 | 25,166 | 2025-12-08 02:20:10 | 73.9% |
| WhiteOak Capital Mid Cap Fund | 30,394 | 0.06 | 2.78 | 63,549 | 2025-12-15 03:10:46 | -52.17% |
| WhiteOak Capital Digital Bharat Fund | 26,424 | 0.53 | 2.42 | N/A | N/A | N/A |
| WhiteOak Capital Balanced Advantage Fund | 23,359 | 0.1 | 2.14 | 8,909 | 2025-12-08 02:20:10 | 162.2% |
| WhiteOak Capital ELSS Tax Saver Fund | 9,404 | 0.19 | 0.86 | 13,802 | 2025-12-15 03:10:46 | -31.86% |
| WhiteOak Capital Multi Asset Allocation Fund - Direct Plan | 7,603 | 0.01 | 0.7 | N/A | N/A | N/A |
| WhiteOak Capital Balanced Hybrid Fund | 3,556 | 0.12 | 0.33 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 61.40 | 71.56 | 47.73 | 14.28 | 40.62 |
| Diluted EPS (Rs.) | 61.40 | 71.56 | 47.73 | 14.28 | 40.62 |
| Cash EPS (Rs.) | 67.53 | 77.01 | 54.73 | 21.03 | 45.39 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 309.24 | 290.41 | 228.11 | 184.38 | 231.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 309.24 | 290.41 | 228.11 | 184.38 | 231.41 |
| Revenue From Operations / Share (Rs.) | 316.08 | 308.72 | 237.00 | 185.73 | 176.84 |
| PBDIT / Share (Rs.) | 89.10 | 101.34 | 71.28 | 26.78 | 58.16 |
| PBIT / Share (Rs.) | 83.48 | 95.91 | 64.29 | 21.03 | 53.38 |
| PBT / Share (Rs.) | 83.19 | 95.55 | 63.91 | 20.73 | 52.96 |
| Net Profit / Share (Rs.) | 61.91 | 71.57 | 47.74 | 15.28 | 40.62 |
| NP After MI And SOA / Share (Rs.) | 61.91 | 71.57 | 47.74 | 15.28 | 40.62 |
| PBDIT Margin (%) | 28.18 | 32.82 | 30.07 | 14.41 | 32.88 |
| PBIT Margin (%) | 26.41 | 31.06 | 27.12 | 11.32 | 30.18 |
| PBT Margin (%) | 26.32 | 30.95 | 26.96 | 11.16 | 29.95 |
| Net Profit Margin (%) | 19.58 | 23.18 | 20.14 | 8.22 | 22.96 |
| NP After MI And SOA Margin (%) | 19.58 | 23.18 | 20.14 | 8.22 | 22.96 |
| Return on Networth / Equity (%) | 20.01 | 24.64 | 20.92 | 8.28 | 17.55 |
| Return on Capital Employeed (%) | 25.25 | 31.36 | 26.84 | 10.84 | 22.57 |
| Return On Assets (%) | 14.13 | 17.19 | 14.61 | 5.55 | 13.33 |
| Asset Turnover Ratio (%) | 0.73 | 0.83 | 0.74 | 0.56 | 0.56 |
| Current Ratio (X) | 1.93 | 2.07 | 2.07 | 2.09 | 3.11 |
| Quick Ratio (X) | 1.93 | 2.07 | 2.07 | 2.09 | 3.11 |
| Dividend Payout Ratio (NP) (%) | 20.53 | 13.97 | 14.66 | 42.58 | 7.38 |
| Dividend Payout Ratio (CP) (%) | 18.82 | 12.98 | 12.79 | 30.94 | 6.60 |
| Earning Retention Ratio (%) | 79.47 | 86.03 | 85.34 | 57.42 | 92.62 |
| Cash Earning Retention Ratio (%) | 81.18 | 87.02 | 87.21 | 69.06 | 93.40 |
| Interest Coverage Ratio (X) | 312.81 | 285.58 | 187.09 | 88.51 | 138.44 |
| Interest Coverage Ratio (Post Tax) (X) | 218.33 | 202.68 | 126.28 | 51.51 | 97.68 |
| Enterprise Value (Cr.) | 1988.60 | 3091.48 | 1658.15 | 1054.42 | 1353.67 |
| EV / Net Operating Revenue (X) | 2.39 | 3.74 | 2.61 | 2.12 | 2.64 |
| EV / EBITDA (X) | 8.48 | 11.40 | 8.69 | 14.71 | 8.01 |
| MarketCap / Net Operating Revenue (X) | 2.54 | 3.83 | 2.69 | 2.23 | 2.72 |
| Retention Ratios (%) | 79.46 | 86.02 | 85.33 | 57.41 | 92.61 |
| Price / BV (X) | 2.59 | 4.07 | 2.80 | 2.25 | 2.08 |
| Price / Net Operating Revenue (X) | 2.54 | 3.83 | 2.69 | 2.23 | 2.72 |
| EarningsYield | 0.07 | 0.06 | 0.07 | 0.03 | 0.08 |
After reviewing the key financial ratios for Nucleus Software Exports Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 61.40. This value is within the healthy range. It has decreased from 71.56 (Mar 24) to 61.40, marking a decrease of 10.16.
- For Diluted EPS (Rs.), as of Mar 25, the value is 61.40. This value is within the healthy range. It has decreased from 71.56 (Mar 24) to 61.40, marking a decrease of 10.16.
- For Cash EPS (Rs.), as of Mar 25, the value is 67.53. This value is within the healthy range. It has decreased from 77.01 (Mar 24) to 67.53, marking a decrease of 9.48.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 309.24. It has increased from 290.41 (Mar 24) to 309.24, marking an increase of 18.83.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 309.24. It has increased from 290.41 (Mar 24) to 309.24, marking an increase of 18.83.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 316.08. It has increased from 308.72 (Mar 24) to 316.08, marking an increase of 7.36.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 89.10. This value is within the healthy range. It has decreased from 101.34 (Mar 24) to 89.10, marking a decrease of 12.24.
- For PBIT / Share (Rs.), as of Mar 25, the value is 83.48. This value is within the healthy range. It has decreased from 95.91 (Mar 24) to 83.48, marking a decrease of 12.43.
- For PBT / Share (Rs.), as of Mar 25, the value is 83.19. This value is within the healthy range. It has decreased from 95.55 (Mar 24) to 83.19, marking a decrease of 12.36.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 61.91. This value is within the healthy range. It has decreased from 71.57 (Mar 24) to 61.91, marking a decrease of 9.66.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 61.91. This value is within the healthy range. It has decreased from 71.57 (Mar 24) to 61.91, marking a decrease of 9.66.
- For PBDIT Margin (%), as of Mar 25, the value is 28.18. This value is within the healthy range. It has decreased from 32.82 (Mar 24) to 28.18, marking a decrease of 4.64.
- For PBIT Margin (%), as of Mar 25, the value is 26.41. This value exceeds the healthy maximum of 20. It has decreased from 31.06 (Mar 24) to 26.41, marking a decrease of 4.65.
- For PBT Margin (%), as of Mar 25, the value is 26.32. This value is within the healthy range. It has decreased from 30.95 (Mar 24) to 26.32, marking a decrease of 4.63.
- For Net Profit Margin (%), as of Mar 25, the value is 19.58. This value exceeds the healthy maximum of 10. It has decreased from 23.18 (Mar 24) to 19.58, marking a decrease of 3.60.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.58. This value is within the healthy range. It has decreased from 23.18 (Mar 24) to 19.58, marking a decrease of 3.60.
- For Return on Networth / Equity (%), as of Mar 25, the value is 20.01. This value is within the healthy range. It has decreased from 24.64 (Mar 24) to 20.01, marking a decrease of 4.63.
- For Return on Capital Employeed (%), as of Mar 25, the value is 25.25. This value is within the healthy range. It has decreased from 31.36 (Mar 24) to 25.25, marking a decrease of 6.11.
- For Return On Assets (%), as of Mar 25, the value is 14.13. This value is within the healthy range. It has decreased from 17.19 (Mar 24) to 14.13, marking a decrease of 3.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.73. It has decreased from 0.83 (Mar 24) to 0.73, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.93, marking a decrease of 0.14.
- For Quick Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.93, marking a decrease of 0.14.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.53. This value is within the healthy range. It has increased from 13.97 (Mar 24) to 20.53, marking an increase of 6.56.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 18.82. This value is below the healthy minimum of 20. It has increased from 12.98 (Mar 24) to 18.82, marking an increase of 5.84.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.47. This value exceeds the healthy maximum of 70. It has decreased from 86.03 (Mar 24) to 79.47, marking a decrease of 6.56.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 81.18. This value exceeds the healthy maximum of 70. It has decreased from 87.02 (Mar 24) to 81.18, marking a decrease of 5.84.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 312.81. This value is within the healthy range. It has increased from 285.58 (Mar 24) to 312.81, marking an increase of 27.23.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 218.33. This value is within the healthy range. It has increased from 202.68 (Mar 24) to 218.33, marking an increase of 15.65.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,988.60. It has decreased from 3,091.48 (Mar 24) to 1,988.60, marking a decrease of 1,102.88.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 3.74 (Mar 24) to 2.39, marking a decrease of 1.35.
- For EV / EBITDA (X), as of Mar 25, the value is 8.48. This value is within the healthy range. It has decreased from 11.40 (Mar 24) to 8.48, marking a decrease of 2.92.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has decreased from 3.83 (Mar 24) to 2.54, marking a decrease of 1.29.
- For Retention Ratios (%), as of Mar 25, the value is 79.46. This value exceeds the healthy maximum of 70. It has decreased from 86.02 (Mar 24) to 79.46, marking a decrease of 6.56.
- For Price / BV (X), as of Mar 25, the value is 2.59. This value is within the healthy range. It has decreased from 4.07 (Mar 24) to 2.59, marking a decrease of 1.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has decreased from 3.83 (Mar 24) to 2.54, marking a decrease of 1.29.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Nucleus Software Exports Ltd:
- Net Profit Margin: 19.58%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 25.25% (Industry Average ROCE: 20.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 20.01% (Industry Average ROE: 18.63%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 218.33
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.93
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.8 (Industry average Stock P/E: 42.95)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 19.58%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 33-35, Thyagraj Nagar Market, New Delhi Delhi 110003 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. S M Acharya | Chairman(NonExe.&Ind.Director) |
| Mr. Vishnu R Dusad | Managing Director |
| Mr. Anurag Mantri | Executive Director & COO |
| Mr. Parag Bhise | Executive Director & CEO |
| Mr. Shekar Viswanathan | Ind. Non-Executive Director |
| Dr. Ritika Dusad | Executive Director |
| Mr. Prakash Chandra Kandpal | Ind. Non-Executive Director |
| Ms. Yasmin Javeri Krishan | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Nucleus Software Exports Ltd?
Nucleus Software Exports Ltd's intrinsic value (as of 02 February 2026) is ₹857.15 which is 5.29% lower the current market price of ₹905.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,383 Cr. market cap, FY2025-2026 high/low of ₹1,378/724, reserves of ₹822 Cr, and liabilities of ₹1,230 Cr.
What is the Market Cap of Nucleus Software Exports Ltd?
The Market Cap of Nucleus Software Exports Ltd is 2,383 Cr..
What is the current Stock Price of Nucleus Software Exports Ltd as on 02 February 2026?
The current stock price of Nucleus Software Exports Ltd as on 02 February 2026 is ₹905.
What is the High / Low of Nucleus Software Exports Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Nucleus Software Exports Ltd stocks is ₹1,378/724.
What is the Stock P/E of Nucleus Software Exports Ltd?
The Stock P/E of Nucleus Software Exports Ltd is 14.8.
What is the Book Value of Nucleus Software Exports Ltd?
The Book Value of Nucleus Software Exports Ltd is 322.
What is the Dividend Yield of Nucleus Software Exports Ltd?
The Dividend Yield of Nucleus Software Exports Ltd is 1.38 %.
What is the ROCE of Nucleus Software Exports Ltd?
The ROCE of Nucleus Software Exports Ltd is 22.6 %.
What is the ROE of Nucleus Software Exports Ltd?
The ROE of Nucleus Software Exports Ltd is 16.8 %.
What is the Face Value of Nucleus Software Exports Ltd?
The Face Value of Nucleus Software Exports Ltd is 10.0.